SCHEMBL8124341

SCHEMBL8124341

Cc1cccc(COC(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)[C@@H](O)C[C@H](Cc2ccccc2)NC(=O)OCc2cccnc2)C(C)C)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.52
CA2 P00918 1/20 0.51
CYP2D6 P10635 2/20 0.49
CYP2C19 P33261 2/20 0.49
MEN1 O00255 1/20 0.49
SLC22A2 O15244 1/20 0.49
SLC22A1 O15245 1/20 0.49
ABCC3 O15438 1/20 0.49
ABCC4 O15439 1/20 0.49
MLNR O43193 1/20 0.49
NR1I2 O75469 1/20 0.49
SLCO2B1 O94956 1/20 0.49
ABCB11 O95342 1/20 0.49
ALDH1A1 P00352 1/20 0.49
PGR P06401 1/20 0.49
ABCB1 P08183 1/20 0.49
HTR1A P08908 1/20 0.49
ADRA2A P08913 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8124337 1.00 CYP3A4 (0.52) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL7329941 0.97 CYP3A4 (0.53) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL7329960 0.97 CYP3A4 (0.53) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL7309306 0.92 CYP3A4 (0.51) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL7302611 0.91 CYP3A4 (0.64) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL7312307 0.91 CYP3A4 (0.58) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL13240259 0.90 CA2 (0.62) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL2771252 0.90 CA2 (0.62) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL7307494 0.89 CYP3A4 (0.51) CYP3A4CA2CYP2D6CYP2C19MEN1
SCHEMBL7298935 0.88 CYP3A4 (0.56) CYP3A4CA2CYP2D6CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed